Lifeward (NASDAQ:LFWD) Trading 1.5% Higher – Here’s What Happened

Lifeward Ltd. (NASDAQ:LFWD) rose 1.5% during mid-day trading on Monday . The stock traded as high as $0.77 and last traded at $0.75. Approximately 236,331 shares traded hands during trading, a decline of 45% from the average daily volume of 429,632 shares. The stock had previously closed at $0.74.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Lifeward in a research note on Wednesday, October 8th. Three analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $9.00.

Lifeward Stock Up 1.5%

The company has a market cap of $11.78 million, a price-to-earnings ratio of -0.24 and a beta of 0.19. The stock has a fifty day moving average price of $0.66 and a two-hundred day moving average price of $0.97.

Lifeward (NASDAQ:LFWD) last issued its earnings results on Thursday, August 14th. The company reported ($0.58) EPS for the quarter, missing the consensus estimate of ($0.25) by ($0.33). Lifeward had a negative return on equity of 137.91% and a negative net margin of 121.80%.The business had revenue of $5.72 million for the quarter, compared to analyst estimates of $6.62 million. Lifeward has set its FY 2025 guidance at EPS. Analysts predict that Lifeward Ltd. will post -1.78 earnings per share for the current fiscal year.

Lifeward Company Profile

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.